GlassScriptPhysician profile
Carol A Addy
NPI 1356472559
$5,850.84
in general payments reported to CMS, 2019-2025
49 companies · $860 in 2025
The $860 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,181 · 2022: $1,170 · 2023: $1,176 · 2024: $1,464 · 2025: $860.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,450 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,450.01 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $916.90 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Astrazeneca Pharmaceuticals LP | $828.55 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $486.61 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $390.63 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $315.14 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $300.18 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $237.48 | 2021-2023 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $223.49 | 2022-2025 | Rexulti |
| Antares Pharma, INC. | $200.32 | 2021-2025 | Xyosted |
| Inspire Medical Systems, INC. | $167.45 | 2024-2025 | Inspire |
| Biohaven Pharmaceuticals, INC. | $109.09 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $98.29 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $98.19 | 2021-2023 | |
| Amarin Pharma, INC. | $93.07 | 2021-2022 | |
| Tris Pharma INC | $80.09 | 2022-2024 | Dyanavel Xr |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $79.76 | 2021-2022 | |
| Amgen INC. | $78.85 | 2023-2025 | Repatha, Evenity, Prolia |
| Phathom Pharmaceuticals, INC. | $75.60 | 2024-2025 | Voquezna |
| Astellas Pharma US INC | $75.37 | 2022-2025 | Veozah |
| Daiichi Sankyo INC. | $69.57 | 2021-2022 | |
| Axsome Therapeutics, INC. | $65.71 | 2023 | Auvelity, Sunosi |
| Kowa Pharmaceuticals America, INC. | $62.65 | 2021-2025 | Zoryve |
| Biohaven Pharmaceutical Holding Company LTD. | $60.94 | 2022 | |
| Tolmar, INC. | $51.14 | 2023-2025 | Jatenzo |
| Currax Pharmaceuticals LLC | $50.00 | 2023 | Nexletol |
| Lundbeck LLC | $49.43 | 2025 | Vyepti |
| Novartis Pharmaceuticals Corporation | $42.33 | 2021-2022 | |
| Abbott Laboratories | $38.84 | 2021-2023 | Freestyle Libre 2 |
| Impel Pharmaceuticals INC. | $38.11 | 2023 | Trudhesa |
| Exact Sciences Corporation | $37.76 | 2024-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $37.61 | 2024 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $37.42 | 2021-2024 | Gardasil 9, Capvaxive, Gardasil |
| Seqirus USA INC | $34.44 | 2022-2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Clarus Therapeutics INC. | $33.55 | 2021 | |
| Ironshore Pharmaceuticals INC. | $23.95 | 2023 | Jornay Pm |
| Acella Pharmaceuticals, LLC | $23.17 | 2024 | NP Thyroid 60 |
| Eisai INC. | $22.78 | 2021 | |
| Sanofi Pasteur INC. | $22.34 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.26 | 2024 | Trulance, Xifaxan |
| Ibsa Pharma INC. | $21.86 | 2025 | Tirosint, Flector, Licart |
| Genentech USA, INC. | $20.44 | 2021 | |
| Supernus Pharmaceuticals, INC. | $19.44 | 2022 | Xyosted, Tlando |
| Bausch Health US, LLC | $18.25 | 2022 | |
| Halozyme INC | $17.85 | 2023 | |
| Neos Therapeutics, LP | $16.60 | 2022 | |
| Idorsia Pharmaceuticals US INC | $15.58 | 2023 | Quviviq |
| Upsher-Smith Laboratories LLC | $15.36 | 2021 | |
| Medtronic, INC. | $15.33 | 2024 | Intellis Adaptivestim |
| Jazz Pharmaceuticals INC. | $11.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol Addy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.